The yap/taz signaling pathway in the tumor microenvironment and carcinogenesis: Current knowledge and therapeutic promises
Abstract:
The yes-associated protein (YAP) and the transcriptional coactivator with PDZ-binding motif (TAZ) are transcriptional coactivators, members of the Hippo signaling pathway, which play a critical role in cell growth regulation, embryonic development, regeneration, proliferation, and cancer origin and progression. The mechanism involves the nuclear binding of the un-phosphorylated YAP/TAZ complex to release the transcriptional enhanced associate domain (TEAD) from its repressors. The active ternary complex is responsible for the aforementioned biological effects. Overexpression of YAP/TAZ has been reported in cancer stem cells and tumor resistance. The resistance involves chemotherapy, targeted therapy, and immunotherapy. This review provides an overview of YAP/TAZ pathways’ role in carcinogenesis and tumor microenvironment. Potential therapeutic alternatives are also discussed.
Año de publicación:
2022
Keywords:
- Hippo signaling pathway
- immunotherapy
- Carcinogenesis
- YAP/TAZ
- Drug resistance
- cell proliferation
- Neoplastic stem cells
- Chemoresistance
- tumor microenvironment
- TEAD
Fuente:

Tipo de documento:
Review
Estado:
Acceso abierto
Áreas de conocimiento:
- Cáncer
- Cáncer
Áreas temáticas:
- Medicina y salud
- Enfermedades